Ignite Creation Date:
2024-05-06 @ 1:10 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03958383
Status:
SUSPENDED
Last Update Posted:
2024-02-14
First Post:
2019-05-07
Brief Title:
IT-hu1418-IL2 With Radiation Nivolumab and Ipilimumab for Melanoma
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Organization Data
Organization:
University of Wisconsin Madison
Class:
OTHER
Study ID:
UW16134
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Wisconsin Madison
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Provenance Biopharmaceuticals | UNKNOWN |
| National Cancer Institute NCI | NIH |
| Bristol-Myers Squibb | INDUSTRY |
| AnYxis Immuno-Oncology GmbH | UNKNOWN |